Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
118.64 USD | +0.30% | +3.43% | +8.82% |
09-18 | Merck Secures FDA Approval for Keytruda Combination Therapy as Malignant Pleural Mesothelioma Treatment | MT |
09-18 | Merck Gets First FDA Approval of Keytruda in Malignant Pleural Mesothelioma | DJ |
MarketScreener is also available in this country: United States.
Switch edition